Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol

Megadott ok: The study was discontinued prior to initiation because startup activities could not be completed within the planned timelines.

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálat adatai

Ki végzi
ResMed
Azonosító
NCT05255744
A regiszteradat frissítve
2026. április 27.
Eredeti leírás
Each Whitsunday mask or AirFit N30i Quiet mask is worn for 7 nights. The overall purpose of this study is to evaluate the performance of the Whitsundays nasal mask system (a prototype mask) compared to the ResMed AirFit N30i Quiet mask system (a benchmark mask) in relation to seal, comfort, usability, overall performance, and efficacy.A teljes eredeti leírásKevesebb

Assessment of the Seal, Comfort, Usability and Performance of the Prototype Whitsundays Nasal Mask System in the Singapore Home Environment

Each Whitsunday mask or AirFit N30i Quiet mask is worn for 7 nights. The overall purpose of this study is to evaluate the performance of the Whitsundays nasal mask system (a prototype mask) compared to the ResMed AirFit N30i Quiet mask system (a benchmark mask) in relation to seal, comfort, usability, overall performance, and efficacy.

Bevonási feltételek: Patients willing to give written informed consent; Patients who can read and comprehend English; Patients who ≥ 21 years of age; Patients being treated for OSA with PAP therapy for ≥ 6 months; Patients currently using a suitable mask system (any nasal mask ); Patients who can trial the masks for up to 7 nights each.

Kizáró feltételek: Patients with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury; Patients using Bilevel flow generators; Patients who are or may be pregnant; Patients believed to be unsuitable for inclusion by the researcher.

ClinicalTrials.gov NCT05255744